Cargando…

The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study

BACKGROUND: Retrospective studies have shown adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL) have superior survival when treated in pediatric versus adult centers (locus of care; LOC). Several adult centers recently adopted pediatric protocols. Whether this has narrowed LO...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Sumit, Pole, Jason D., Baxter, Nancy N., Sutradhar, Rinku, Lau, Cindy, Nagamuthu, Chenthila, Nathan, Paul C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536996/
https://www.ncbi.nlm.nih.gov/pubmed/30912628
http://dx.doi.org/10.1002/cam4.2096
_version_ 1783421902585331712
author Gupta, Sumit
Pole, Jason D.
Baxter, Nancy N.
Sutradhar, Rinku
Lau, Cindy
Nagamuthu, Chenthila
Nathan, Paul C.
author_facet Gupta, Sumit
Pole, Jason D.
Baxter, Nancy N.
Sutradhar, Rinku
Lau, Cindy
Nagamuthu, Chenthila
Nathan, Paul C.
author_sort Gupta, Sumit
collection PubMed
description BACKGROUND: Retrospective studies have shown adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL) have superior survival when treated in pediatric versus adult centers (locus of care; LOC). Several adult centers recently adopted pediatric protocols. Whether this has narrowed LOC disparities in real–world settings is unknown. METHODS: The IMPACT Cohort is an Ontario population–based cohort that captured demographic, disease and treatment (treatment protocol, chemotherapy doses) data for all 15‐21 year olds diagnosed with ALL 1992‐2011. Cancer outcomes were determined by chart abstraction and linkage to provincial healthcare databases. Treatment protocols were classified as pediatric‐ or adult‐based. We examined predictors of outcome, including LOC, protocol, disease biology, and time period. RESULTS: Of 271 patients, 152 (56%) received therapy at adult centers. 5‐year event‐free survival (EFS ± SE) among AYA at pediatric vs adult centers was 72% ± 4% vs 56% ± 4% (P = 0.03); 5‐year overall survival (OS) was 82% ± 4% vs 64% ± 4% (P < 0.001). After adjustment, OS remained inferior at adult centers (hazard ratio 2.5; 95% confidence interval 1.1‐6.1; P = 0.04). In the most recent period (2006‐2011), 39/59 (66%) AYA treated at adult centers received pediatric protocols. These AYA had outcomes superior to the 20 AYA treated on adult protocols, but inferior to the 44 AYA treated at pediatric centers (EFS 72% ± 5% vs 60% ± 9% vs 81% ± 6%; P = 0.02; OS 77% ± 7% vs 65% ± 11% vs 91% ± 4%; P = 0.004). Induction deaths and treatment–related mortality did not vary by LOC. CONCLUSIONS: Survival disparities between AYA with ALL treated in pediatric vs adult centers have persisted over time, partially attributable to incomplete adoption of pediatric protocols by adult centers. Although pediatric protocol use has improved survival, residual disparities remain, perhaps due to other differences in care between adult and pediatric centers.
format Online
Article
Text
id pubmed-6536996
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65369962019-06-03 The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study Gupta, Sumit Pole, Jason D. Baxter, Nancy N. Sutradhar, Rinku Lau, Cindy Nagamuthu, Chenthila Nathan, Paul C. Cancer Med Clinical Cancer Research BACKGROUND: Retrospective studies have shown adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL) have superior survival when treated in pediatric versus adult centers (locus of care; LOC). Several adult centers recently adopted pediatric protocols. Whether this has narrowed LOC disparities in real–world settings is unknown. METHODS: The IMPACT Cohort is an Ontario population–based cohort that captured demographic, disease and treatment (treatment protocol, chemotherapy doses) data for all 15‐21 year olds diagnosed with ALL 1992‐2011. Cancer outcomes were determined by chart abstraction and linkage to provincial healthcare databases. Treatment protocols were classified as pediatric‐ or adult‐based. We examined predictors of outcome, including LOC, protocol, disease biology, and time period. RESULTS: Of 271 patients, 152 (56%) received therapy at adult centers. 5‐year event‐free survival (EFS ± SE) among AYA at pediatric vs adult centers was 72% ± 4% vs 56% ± 4% (P = 0.03); 5‐year overall survival (OS) was 82% ± 4% vs 64% ± 4% (P < 0.001). After adjustment, OS remained inferior at adult centers (hazard ratio 2.5; 95% confidence interval 1.1‐6.1; P = 0.04). In the most recent period (2006‐2011), 39/59 (66%) AYA treated at adult centers received pediatric protocols. These AYA had outcomes superior to the 20 AYA treated on adult protocols, but inferior to the 44 AYA treated at pediatric centers (EFS 72% ± 5% vs 60% ± 9% vs 81% ± 6%; P = 0.02; OS 77% ± 7% vs 65% ± 11% vs 91% ± 4%; P = 0.004). Induction deaths and treatment–related mortality did not vary by LOC. CONCLUSIONS: Survival disparities between AYA with ALL treated in pediatric vs adult centers have persisted over time, partially attributable to incomplete adoption of pediatric protocols by adult centers. Although pediatric protocol use has improved survival, residual disparities remain, perhaps due to other differences in care between adult and pediatric centers. John Wiley and Sons Inc. 2019-03-26 /pmc/articles/PMC6536996/ /pubmed/30912628 http://dx.doi.org/10.1002/cam4.2096 Text en © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Cancer Research
Gupta, Sumit
Pole, Jason D.
Baxter, Nancy N.
Sutradhar, Rinku
Lau, Cindy
Nagamuthu, Chenthila
Nathan, Paul C.
The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study
title The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study
title_full The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study
title_fullStr The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study
title_full_unstemmed The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study
title_short The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study
title_sort effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: an impact cohort study
topic Clinical Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536996/
https://www.ncbi.nlm.nih.gov/pubmed/30912628
http://dx.doi.org/10.1002/cam4.2096
work_keys_str_mv AT guptasumit theeffectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy
AT polejasond theeffectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy
AT baxternancyn theeffectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy
AT sutradharrinku theeffectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy
AT laucindy theeffectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy
AT nagamuthuchenthila theeffectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy
AT nathanpaulc theeffectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy
AT guptasumit effectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy
AT polejasond effectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy
AT baxternancyn effectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy
AT sutradharrinku effectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy
AT laucindy effectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy
AT nagamuthuchenthila effectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy
AT nathanpaulc effectofadoptingpediatricprotocolsinadolescentsandyoungadultswithacutelymphoblasticleukemiainpediatricvsadultcentersanimpactcohortstudy